Research on Novel Treatment Approaches and Scientific Advances From Merck's Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025Business Wire • 05/13/25
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to knowCNBC • 05/12/25
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - YetSeeking Alpha • 05/12/25
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug CostsZacks Investment Research • 05/12/25
Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior PrincipalGlobeNewsWire • 05/12/25
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De SotoBusiness Wire • 05/08/25
Merck to Participate in the Bank of America 2025 Global Healthcare ConferenceBusiness Wire • 05/07/25
Why A Short Strangle Trade Might Be Best For Volatile Stocks Like MerckInvestors Business Daily • 05/06/25
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loomCNBC • 04/30/25